Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 100

1.

Perfusion Defect-concordant Progression of Unilateral Refractory Pulmonary MAC Disease.

Asakura T, Yamada Y, Ishii M, Ebisudani T, Ueda S, Betsuyaku T, Hasegawa N.

Am J Respir Crit Care Med. 2018 May 11. doi: 10.1164/rccm.201801-0173IM. [Epub ahead of print] No abstract available.

PMID:
29749791
2.

Aspergillus precipitating antibody in patients with Mycobacterium avium complex lung disease: A cross-sectional study.

Suzuki S, Asakura T, Namkoong H, Okamori S, Yagi K, Kamata H, Uwamino Y, Funatsu Y, Nakano Y, Nishimura T, Ishii M, Ebihara T, Betsuyaku T, Hasegawa N.

Respir Med. 2018 May;138:1-6. doi: 10.1016/j.rmed.2018.03.013. Epub 2018 Mar 12.

PMID:
29724379
3.

Clarithromycin expands CD11b+Gr-1+ cells via the STAT3/Bv8 axis to ameliorate lethal endotoxic shock and post-influenza bacterial pneumonia.

Namkoong H, Ishii M, Fujii H, Yagi K, Asami T, Asakura T, Suzuki S, Hegab AE, Kamata H, Tasaka S, Atarashi K, Nakamoto N, Iwata S, Honda K, Kanai T, Hasegawa N, Koyasu S, Betsuyaku T.

PLoS Pathog. 2018 Apr 5;14(4):e1006955. doi: 10.1371/journal.ppat.1006955. eCollection 2018 Apr.

4.

Anti-inflammatory roles of mesenchymal stromal cells during acute Streptococcus pneumoniae pulmonary infection in mice.

Asami T, Ishii M, Namkoong H, Yagi K, Tasaka S, Asakura T, Suzuki S, Kamo T, Okamori S, Kamata H, Zhang H, Hegab AE, Hasegawa N, Betsuyaku T.

Cytotherapy. 2018 Mar;20(3):302-313. doi: 10.1016/j.jcyt.2018.01.003. Epub 2018 Feb 12.

PMID:
29397306
5.

Natural history of Mycobacterium fortuitum pulmonary infection presenting with migratory infiltrates: a case report with microbiological analysis.

Okamori S, Asakura T, Nishimura T, Tamizu E, Ishii M, Yoshida M, Fukano H, Hayashi Y, Fujita M, Hoshino Y, Betsuyaku T, Hasegawa N.

BMC Infect Dis. 2018 Jan 2;18(1):1. doi: 10.1186/s12879-017-2892-9.

6.

Suspected accelerated disease progression after discontinuation of nintedanib in patients with idiopathic pulmonary fibrosis: Two case reports.

Okamori S, Asakura T, Masuzawa K, Yasuda H, Kamata H, Ishii M, Betsuyaku T.

Medicine (Baltimore). 2017 Dec;96(49):e9081. doi: 10.1097/MD.0000000000009081.

7.

Impact of chronic Pseudomonas aeruginosa infection on health-related quality of life in Mycobacterium avium complex lung disease.

Kamata H, Asakura T, Suzuki S, Namkoong H, Yagi K, Funatsu Y, Okamori S, Uno S, Uwamino Y, Fujiwara H, Nishimura T, Ishii M, Betsuyaku T, Hasegawa N.

BMC Pulm Med. 2017 Dec 13;17(1):198. doi: 10.1186/s12890-017-0544-x.

8.

Clinical characteristics of pulmonary Mycobacterium lentiflavum disease in adult patients.

Yagi K, Morimoto K, Ishii M, Namkoong H, Okamori S, Asakura T, Suzuki S, Asami T, Uwamino Y, Funatsu Y, Fujiwara H, Kamata H, Nishimura T, Betsuyaku T, Kurashima A, Hasegawa N.

Int J Infect Dis. 2018 Feb;67:65-69. doi: 10.1016/j.ijid.2017.12.001. Epub 2017 Dec 7.

9.

Enhanced Plasmonic Wavelength Selective Infrared Emission Combined with Microheater.

Ishihara H, Masuno K, Ishii M, Kumagai S, Sasaki M.

Materials (Basel). 2017 Sep 14;10(9). pii: E1085. doi: 10.3390/ma10091085.

10.

Clinical and radiological characteristics of patients with late-onset severe restrictive lung defect after hematopoietic stem cell transplantation.

Namkoong H, Ishii M, Mori T, Sugiura H, Tasaka S, Sakurai M, Koda Y, Kato J, Hasegawa N, Okamoto S, Betsuyaku T.

BMC Pulm Med. 2017 Sep 7;17(1):123. doi: 10.1186/s12890-017-0466-7.

11.

The efficacy, safety, and feasibility of inhaled amikacin for the treatment of difficult-to-treat non-tuberculous mycobacterial lung diseases.

Yagi K, Ishii M, Namkoong H, Asami T, Iketani O, Asakura T, Suzuki S, Sugiura H, Yamada Y, Nishimura T, Fujiwara H, Funatsu Y, Uwamino Y, Kamo T, Tasaka S, Betsuyaku T, Hasegawa N.

BMC Infect Dis. 2017 Aug 9;17(1):558. doi: 10.1186/s12879-017-2665-5.

12.

Sternoclavicular joint osteomyelitis extending to lung abscess complicated by Staphylococcal infective endocarditis.

Masuzawa K, Asakura T, Ishii M, Yasuda H, Sugiura H, Betsuyaku T.

IDCases. 2017 May 31;9:36-37. doi: 10.1016/j.idcr.2017.04.005. eCollection 2017. No abstract available.

13.

Endocrine Emergencies With Neurologic Manifestations.

Ishii M.

Continuum (Minneap Minn). 2017 Jun;23(3, Neurology of Systemic Disease):778-801. doi: 10.1212/CON.0000000000000467.

14.

Effects of the common polymorphism in the human aldehyde dehydrogenase 2 (ALDH2) gene on the lung.

Kuroda A, Hegab AE, Jingtao G, Yamashita S, Hizawa N, Sakamoto T, Yamada H, Suzuki S, Ishii M, Namkoong H, Asakura T, Ozaki M, Yasuda H, Hamamoto J, Kagawa S, Soejima K, Betsuyaku T.

Respir Res. 2017 Apr 21;18(1):69. doi: 10.1186/s12931-017-0554-5.

15.

Impact of cavity and infiltration on pulmonary function and health-related quality of life in pulmonary Mycobacterium avium complex disease: A 3-dimensional computed tomographic analysis.

Asakura T, Yamada Y, Namkoong H, Suzuki S, Niijima Y, Kamata H, Funatsu Y, Yagi K, Okamori S, Sugiura H, Ishii M, Jinzaki M, Betsuyaku T, Hasegawa N.

Respir Med. 2017 May;126:9-16. doi: 10.1016/j.rmed.2017.03.010. Epub 2017 Mar 10.

PMID:
28427555
16.

Long-term Outcome of Pulmonary Resection for Nontuberculous Mycobacterial Pulmonary Disease.

Asakura T, Hayakawa N, Hasegawa N, Namkoong H, Takeuchi K, Suzuki S, Ishii M, Betsuyaku T, Abe Y, Ouchi M.

Clin Infect Dis. 2017 Jul 15;65(2):244-251. doi: 10.1093/cid/cix274.

PMID:
28369361
17.

Pulmonary Cryptococcosis Developed from a Nodule after Treatment with Infliximab for Arthritis Associated with Ulcerative Colitis.

Asakura T, Arai D, Ishii M, Takei H, Sugiura H, Takeuchi T, Betsuyaku T.

Ann Am Thorac Soc. 2017 Apr;14(4):603-605. doi: 10.1513/AnnalsATS.201612-952LE. No abstract available.

PMID:
28362530
18.

Pharmacokinetics of intravenous peramivir in the airway epithelial lining fluid of healthy volunteers.

Funatsu Y, Tasaka S, Asami T, Namkoong H, Fujiwara H, Iketani O, Yagi K, Kimizuka Y, Ishii M, Nishimura T, Ogata H, Iwata S, Betsuyaku T, Hasegawa N.

Antivir Ther. 2016;21(7):621-625. doi: 10.3851/IMP3096. Epub 2016 Oct 3.

PMID:
27694694
19.

Successful treatment of non-small-cell lung cancer with afatinib and a glucocorticoid following gefitinib- and erlotinib-induced interstitial lung disease: A case report.

Tani T, Naoki K, Asakura T, Hirano T, Suzuki S, Masuzawa K, Hasegawa H, Kuroda A, Yasuda H, Ishii M, Soejima K, Betsuyaku T.

Mol Clin Oncol. 2016 Oct;5(4):488-490. Epub 2016 Aug 4.

20.

Macrolide-Resistant Mycobacterium avium Complex Lung Disease: Analysis of 102 Consecutive Cases.

Morimoto K, Namkoong H, Hasegawa N, Nakagawa T, Morino E, Shiraishi Y, Ogawa K, Izumi K, Takasaki J, Yoshiyama T, Hoshino Y, Matsuda S, Hayashi Y, Sasaki Y, Ishii M, Kurashima A, Nishimura T, Betsuyaku T, Goto H; Nontuberculous Mycobacteriosis Japan Research Consortium.

Ann Am Thorac Soc. 2016 Nov;13(11):1904-1911.

PMID:
27513168

Supplemental Content

Loading ...
Support Center